High event‐free survival rate with minimum‐dose‐anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group
Hiroyuki Takahashi(Children's Cancer Association of Japan), Souichi Adachi(Kyoto University), Atsushi Ogawa(Niigata Cancer Center Hospital), Keizo Horibe(National Hospital Organization), Yoshiyuki Kosaka(Kobe Gakuin University), Daisuke Tomizawa(National Center For Child Health and Development), Tatsutoshi Nakahata(Kyoto University), Takashi Taga(Erasmus MC), Yuka Yamashita(Kanazawa Medical University), Akira Shimada(Tohoku University), Akio Tawa(Erasmus MC), Miharu Yabe(Tokai University), Akitoshi Kinoshita(St. Marianna University School of Medicine), Hayato Miyachi(Tokai University), Hiromichi Matsushita(Tokyo National Hospital), Yuki Yuza(Tokyo Metropolitan Children's Medical Center), Tomohiko Taki(Kyorin University), Hiroshi Moritake(University of Miyazaki), Tomoyuki Watanabe(Aichi Gakuin University), Akiko Saito(Nagoya University Hospital), Kazutoshi Koike(Ibaraki Children's Hospital), Hideki Nakayama(National Hospital Organization Kyushu Cancer Center), Kazuko Kudo(Shizuoka Children's Hospital), Shotaro Iwamoto(Mie University), Kiminori Terui(Hirosaki University)
Cited by 21
Related Papers
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
|Blood|2012|575
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
|Journal of Clinical Oncology|2015|383